Aravive, Inc.
ARAVDelisted Jan 29, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513818
Aravive, Inc. was delisted on Jan 29, 2024; its insiders filed their last Form 4 on Apr 11, 2023; 30 institutions reported holding it in 13F filings for Q4 2023, worth $825.5K in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Aravive, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +1 vs. Q4 2021
- Shares held
- 5.24M
- +676.8K (+14.8%) vs. Q4 2021
- Total value
- $10.1M
- +$117.9K (+1.2%) vs. Q4 2021
- New holders
- 5
- 6 more added
- Sold out
- 4
- 16 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARAV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $373 |
| Q1 2026 | 1 | $373 |
| Q4 2025 | 2 | $373 |
| Q3 2025 | 1 | $373 |
| Q2 2025 | 1 | $373 |
| Q1 2025 | 1 | $373 |
| Q4 2024 | 2 | $373 |
| Q3 2024 | 1 | $373 |
| Q2 2024 | 1 | $373 |
| Q1 2024 | 3 | $69.4K |
| Q4 2023 | 30 | $825.5K |
| Q3 2023 | 33 | $786.9K |
| Q2 2023 | 35 | $21.5M |
| Q1 2023 | 36 | $36.9M |
| Q4 2022 | 32 | $20.1M |
| Q3 2022 | 28 | $3.24M |
| Q2 2022 | 36 | $5.47M |
| Q1 2022 | 37 | $10.1M |
| Q4 2021 | 36 | $9.99M |
| Q3 2021 | 45 | $17.7M |
| Q2 2021 | 49 | $35.3M |
| Q1 2021 | 59 | $42.8M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Aravive, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Artal Group S.A. | 1,311,291 | $2.53M | 0.11% | 00.0% | Unchanged |
| New Leaf Venture Partners, L.L.C. | 946,423 | $1.83M | 0.90% | 00.0% | Unchanged |
| Armistice Capital, LLC | 934,975 | $1.80M | 0.05% | +934,975 | New |
| Vanguard Group Inc | 457,220 | $882.0K | 0.00% | −63,023−12.1% | Reduced |
| Renaissance Technologies LLC | 277,829 | $536.0K | 0.00% | −64,500−18.8% | Reduced |
| BlackRock Inc. | 172,703 | $333.0K | 0.00% | −1,872−1.1% | Reduced |
| Geode Capital Management, LLC | 129,118 | $249.0K | 0.00% | −20.0% | Reduced |
| Acadian Asset Management LLC | 116,353 | $223.0K | 0.00% | +7,184+6.6% | Added |
| Two Sigma Advisers, LP | 96,848 | $187.0K | 0.00% | −55,200−36.3% | Reduced |
| Dimensional Fund Advisors LP | 92,109 | $178.0K | 0.00% | −320−0.3% | Reduced |
| Bluefin Capital Management, LLC | 71,537 | $138.0K | 0.02% | +71,537 | New |
| Morgan Stanley | 66,549 | $128.0K | 0.00% | −1,716−2.5% | Reduced |
| Millennium Management LLC | 60,938 | $118.0K | 0.00% | −48,453−44.3% | Reduced |
| Bank of New York Mellon Corp | 58,818 | $113.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 57,625 | $111.0K | 0.00% | −10,000−14.8% | Reduced |
| Susquehanna International Group, LLP | 55,865 | $108.0K | 0.00% | +36,209+184.2% | Added |
| Two Sigma Investments, LP | 50,928 | $98.0K | 0.00% | −48,532−48.8% | Reduced |
| UBS Group AG | 41,000 | $79.0K | 0.00% | −9,695−19.1% | Reduced |
| Franklin Resources Inc | 37,800 | $73.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 32,874 | $63.0K | 0.00% | −522−1.6% | Reduced |
| State Street Corp | 31,987 | $62.0K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 25,000 | $48.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 22,569 | $43.0K | 0.00% | +2,501+12.5% | Added |
| Bradley & Co. Private Wealth Management, LLC | 18,339 | $35.0K | 0.03% | +18,339 | New |
| ACT Capital Management, LLC | 17,500 | $34.0K | 0.04% | +7,500+75.0% | Added |
| Simplex Trading, LLC | 15,203 | $29.0K | 0.00% | +12,173+401.7% | Added |
| Geneos Wealth Management Inc. | 12,810 | $24.0K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 11,400 | $22.0K | 0.00% | 00.0% | Unchanged |
| Massmutual Trust Co FSB | 9,300 | $18.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,479 | $3.00K | 0.00% | +1,479 | New |
| Tower Research Capital LLC (TRC) | 1,266 | $2.00K | 0.00% | −3,642−74.2% | Reduced |
| Newbridge Financial Services Group, Inc. | 841 | $2.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 441 | $1.00K | 0.00% | −33,931−98.7% | Reduced |
| BNP Paribas Arbitrage, SA | 346 | $668 | 0.00% | −2−0.6% | Reduced |
| Bank of America Corp | 66 | $0 | 0.00% | −5,234−98.8% | Reduced |
| JPMorgan Chase & Co | 88 | $0 | 0.00% | +69+363.2% | Added |
| Worth Asset Management, LLC | 120 | $0 | 0.00% | +120 | New |
| Walleye Capital LLC | 0 | $0 | 0.00% | −36,987−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,420−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,551−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −650−100.0% | Sold out |